Nupercaine en es it fr

Nupercaine Brand names, Nupercaine Analogs

Nupercaine Brand Names Mixture

  • No information avaliable

Nupercaine Chemical_Formula

C21H27NO

Nupercaine RX_link

No information avaliable

Nupercaine fda sheet

Nupercaine FDA

Nupercaine msds (material safety sheet)

Nupercaine MSDS

Nupercaine Synthesis Reference

No information avaliable

Nupercaine Molecular Weight

309.445 g/mol

Nupercaine Melting Point

No information avaliable

Nupercaine H2O Solubility

No information avaliable

Nupercaine State

Solid

Nupercaine LogP

4.86

Nupercaine Dosage Forms

Tablets for oral administration (25 mg, 50 mg)

Nupercaine Indication

For use in the prevention and symptomatic treatment of peripheral (labyrinthine) vertigo and associated nausea and vomiting that occur in such conditions as Meniere's disease and surgery of the middle and inner ear. Also for the control of nausea and vomiting associated with postoperative states, malignant neoplasms, labyrinthine disturbances, antineoplastic agent therapy, radiation sickness, and infectious diseases.

Nupercaine Pharmacology

No information avaliable

Nupercaine Absorption

Well absorbed from gastrointestinal tract following oral administration.

Nupercaine side effects and Toxicity

Symptoms of overdose include drowsiness (severe); shortness of breath or troubled breathing; unusual tiredness or weakness (severe).

Nupercaine Patient Information

No information avaliable

Nupercaine Organisms Affected

Humans and other mammals